Foundayo (orfoglipron) is the first oral, non-peptide GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or excess weight and a related health condition
It should always be stored in the fridge, but never in the freezer
Introduction Acute coronary syndromes (ACS), such as unstable angina pectoris (uAP), non-ST-elevated myocardial infarction (NSTEMI), and ST-elevated myocardial infarction (STEMI), and chronic coronary syndromes (CCS) replacing the term stable angina in 2019 ESC guidelines, are prevalent conditions with major contributions to morbidity and mortality (Neumann et al., 2020
Naderpoor, N
This medication influences insulin, cortisol, thyroid hormones, estrogen, testosterone, and growth hormones , making it a game-changer for overall metabolic health